Correlations between clinical and MRI involvement in multiple sclerosis: Assessment using T1, T2 and MT histograms

Journal of the Neurological Sciences

Volumn 171, Issue 2, 1999, Pages 121-129

  Iannucci, G ^a   Minicucci, L ^a   Rodegher, M ^a   Sormani, M P ^a,b   Comi, G ^a   Filippi, M ^a  

^a Dept Neurosci Sci Inst Osp S ^*  (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Disability; Magnetic resonance imaging; Magnetization transfer imaging; Multiple sclerosis

Indexed keywords

ADULT; ARTICLE; BRAIN STEM; CEREBELLUM; CONTROLLED STUDY; DEMYELINATING DISEASE; DIAGNOSTIC IMAGING; DISABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ADULT; BRAIN STEM; CEREBELLUM; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS;

EID: 0032743069     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(99)00259-2     Document Type: Article

References (44)

1. Miller D.H., Albert P.S., Barkhof F., Francis G., Frank J.A., Hodgkinson S., et al. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. Ann Neurol. 39:1996;6-16.
2. Filippi M., Miller D.H. MRI in the differential diagnosis and monitoring the treatment of multiple sclerosis. Curr Opin Neurol. 9:1996;176-186.
3. McDonald W.I., Miller D.H., Barnes D. The pathological evolution of multiple sclerosis. Neuropathol Appl Neurobiol. 18:1992;319-334.
4. Lucchinetti C.F., Bruck W., Rodriguez M., Lassmann H. Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis. Brain Pathol. 6:1996;259-274.
5. Brück W., Bitsch A., Kolenda H., Bruck Y., Stiefel M., Lassmann H. Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol. 42:1997;783-793.
6. Barbosa S., Blumhardt L.D., Roberts N., Lock T., Edwards R.H.T. Magnetic resonance relaxation time mapping in multiple sclerosis: Normal appearing white matter and the 'invisible' lesion load. Magn Reson Imaging. 12:1994;33-42.
7. Filippi M., Campi A., Dousset V., Baratti C., Martinelli V., Canal N., et al. A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology. 45:1995;478-482.
8. Filippi M., Horsfield M.A., Campi A., Mammi S., Pereira C., Comi G. Resolution-dependent estimates of lesion volumes in magnetic resonance imaging studies of the brain in multiple sclerosis. Ann Neurol. 38:1995;749-754.
9. 1-weighted MR and quantitative magnetization transfer. Am J Neuroradiol. 16:1995;1473-1479.
10. Narayanan S., Fu L., Pioro E., De Stefano N., Collins D.L., Francis G.S., et al. Imaging of axonal damage in multiple sclerosis: Spatial distribution of magnetic resonance imaging lesions. Ann Neurol. 41:1997;385-391.
11. Rao S.M., Leo G.J., Haughton V.M., St. Aubin-Faubert P., Bernardin L. Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis. Neurology. 39:1989;161-166.
12. Swirsky-Sacchetti T., Mitchell D.R., Seward J., Gonzales C., Lublin F., Knobler R., et al. Neuropsychological and structural brain lesions in multiple sclerosis: A regional analysis. Neurology. 42:1992;1291-1295.
13. Arnett P.A., Rao S.M., Bernardin L., Grafman J., Yetkin F.Z., Lobeck L. Relationship between frontal lobe lesions and Wisconsin Card Sorting Test performance in patients with multiple sclerosis. Neurology. 44:1994;420-425.
14. Foong J., Rozewicz L., Quaghebeur G., Davie C.A., Kartsounis L.D., Thompson A.J., et al. Executive functions in multiple sclerosis. The role of frontal lobe pathology. Brain. 120:1997;15-26.
15. Miller D.H., Newton M.R., van der Poel J.C., du Boulay E.P.G.H., Halliday A.M., Kendall B.E., et al. Magnetic resonance imaging of the optic nerve in optic neuritis. Neurology. 38:1988;175-179.
16. Youl B.D., Turano G., Miller D.H., Towell A.D., MacManus D.G., Moore S.G., et al. The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits. Brain. 114:1991;2437-2450.
17. van Walderveen M.A.A., Kamphorst W., Scheltens Ph., van Waesberghe J.H.T.M., Ravid R., Valk J. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology. 50:1998;1282-1288.
18. Grossman R.I. Magnetization transfer in multiple sclerosis. Ann Neurol. 36:1994;S97-S99.
19. 1-weighted) spin-echo images. Neurology. 45:1995;1684-1690.
20. 1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology. 47:1996;1469-1476.
21. Gass A., Barker G.J., Kidd D., Thorpe S.W., MacManus D., Brennan A., et al. Correlation of magnetization transfer ratio with disability in multiple sclerosis. Ann Neurol. 36:1994;62-67.
22. van Buchem M.A., McGowan J.C., Kolson D.L., Kolson D.L., Polansky M., Grossman R.I. Quantitative volumetric magnetization transfer analysis in multiple sclerosis: estimation of macroscopic and microscopic disease burden. Magn Reson Med. 36:1996;632-636.
23. Ormerod I.E.C., Miller D.H., McDonald W.I., du Boulay E.P.G.H., Rudge P., Kendall B.E., et al. The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study. Brain. 110:1987;1579-1616.
24. Amato M.P., Fratiglioni L., Groppi C., Siracusa G., Amaducci L. Interrater reliability in assessing functional systems and disability on the Kurtzke Scale in multiple sclerosis. Arch Neurol. 45:1988;746-748.
25. Kurtzke J.F. Rating neurological impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology. 33:1983;1444-1452.
26. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol. 13:1983;227-231.
27. Lublin F.D., Reingold S.C. Defining the clinical course of multiple sclerosis: Results of an international survey. Neurology. 46:1996;907-911.
28. Filippi M., Iannucci G., Tortorella C., et al. Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI. Neurology. 52:1999;588-594.
29. Trapp B.D., Peterson J., Ransohoff R.M., Rudick R., Mörk S., Bö L., et al. Axonal transection in the lesions of multiple sclerosis. N Eng J Med. 338:1998;278-285.
30. Dousset V., Brochet B., Vital A., Gross C., Benazzouz A., Boullerne A., et al. Lysolecithin-induced demyelination in primates: Preliminary in vivo study with MR and magnetization transfer. Am J Neuroradiol. 16:1995;225-231.
31. Kimura H., Grossman R.I., Lenkinski R.E., Gonzalez-Scarano F. Proton MR and magnetization transfer ratio in multiple sclerosis: Correlative findings of active versus irreversible plaque disease. Am J Neuroradiol. 17:1996;1539-1547.
32. Dousset V., Armand J.P., Lacost D., Mieze S., Letenneur L., Dartiques J.F., et al. Magnetization transfer study of HIV encephalitis and progressive multifocal leukoencephalopathy. Am J Neuroradiol. 18:1997;895-901.
33. Kimura H., Meaney D.F., McGowan J.C., Grossman R.I., Lenkinsky R.E., Ross D.T., et al. Magnetization transfer imaging of diffuse axonal injury following experimental brain injury in the pig: Characterization by magnetization transfer ratio with histopathologic correlation. J Comp Assist Tomogr. 20:1996;540-546.
34. Brenner R.E., Munro P.M.G., Williams S.C.R., Bell J.D., Barker G.J., Hawkins C.P., et al. The proton NMR spectrum in acute EAE: The significance of the change in the Cho:Cr ratio. Magn Reson Med. 29:1993;737-745.
35. Loevner L.A., Grossman R.I., Cohen J.A., Lexa F.J., Kessler D., Kolson D.L. Microscopic disease in normal-appearing white matter on conventional MR images in patients with multiple sclerosis: Assessment with magnetization-transfer measurements. Radiology. 96:1995;511-515.
36. Thorpe J.W., Barker G.J., Jones S.J., Moseley I., Losseff N., MacManus D.G., et al. Magnetisation transfer ratios and transverse magnetisation decay curves in optic neuritis: Correlation with clinical findings and electrophysiology. J Neurol Neurosurg Psychiatry. 58:1995;487-492.
37. Campi A., Filippi M., Comi G., Scotti G., Gerevini S., Dousset V. Magnetization transfer ratios of enhancing and non-enhancing lesions in multiple sclerosis. Neuroradiology. 38:1996;115-119.
38. 1-weighted images. Am J Neuroradiol. 16:1995;69-77.
39. Petrella J.R., Grossman R.I., McGowan J.C., Campbell G., Cohen J.A. Multiple sclerosis lesions: Relationship between MR enhancement pattern and magnetization transfer effect. Am J Neuroradiol. 17:1996;1041-1049.
40. van Waesberghe J.H.T.M., vanWalderveen M.A.A., de Groot C., Ravid R., Licklama à Nijeholt G.J., Kamphorst W., et al. Postmortem correlation between axonal loss, MTR, and hypointensity on T1 SE in MS. Proceedings of the International Society for Magnetic Resonance in Medicine. 2:1998;1334.
41. Adams C.W.M. Pathology of multiple sclerosis: Progression of the lesion. Br Med Bull. 33:1977;15-20.
42. Allen I.V., McKeown S.R. A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis. J Neurol Sci. 41:1979;81-91.
43. Dousset V., Grossman R.I., Ramer K.N., Schnall M.D., Young L.H., Gonzalez-Scarano F., et al. Experimental allergic encephalomyelitis and multiple sclerosis: Lesion characterization with magnetization transfer imaging. Radiology. 182:1992;483-491.
44. Davie C.A., Barker G.J., Webb S., Tofts P.S., Thompson A.J., Hadig A.E., et al. Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axonal loss. Brain. 118:1995;1583-1592.